ImageneBio (IMA) Net Margin (2020 - 2025)

ImageneBio has disclosed Net Margin across 6 years of filings, most recently posting 1141.0% for Q1 2025.

• Net Margin for Q1 2025 came in at 1141.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was 757.11% (changed N/A YoY), and the FY2023 annual result was 744.17%, down 30370.0% from the prior year.
• Net Margin came in at 1141.0% for Q1 2025 at ImageneBio, down from 176.6% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 13.83% in Q4 2021 to a low of 5376.44% in Q2 2022.
• The 5-year median for Net Margin is 372.4% (2021), against an average of 1021.36%.
• Across the five-year window, Net Margin soared 4009537 bps in 2021 and sank 501913 bps in 2022, its largest moves.
• ImageneBio's Net Margin stood at 13.83% in 2021, then plunged by 1970 bps to 258.66% in 2022, then tumbled by 1053 bps to 2981.94% in 2023, then surged by 94 bps to 176.6% in 2024, then plunged by 546 bps to 1141.0% in 2025.
• The last three Net Margin figures came in at 1141.0% (Q1 2025), 176.6% (Q3 2024), and 2981.94% (Q4 2023), per Business Quant data.